These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37499292)

  • 1. Associations between glucagon prescribing, hospital admissions for hypoglycaemia and continuous glucose monitoring metrics in adults with type 1 diabetes.
    Stimson RH; Dover AR; Strachan MWJ; Wright RJ; Lyall MJ; Jeeyavudeen MS; Forbes S; Gibb FW
    J Diabetes Complications; 2023 Sep; 37(9):108561. PubMed ID: 37499292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol: a randomised controlled proof-of-concept real-world study - does maximising time in range using hybrid closed loop insulin delivery and a low carbohydrate diet restore the glucagon response to hypoglycaemia in adults with type 1 diabetes?
    Baxter F; Baillie N; Forbes S
    BMJ Open; 2022 Dec; 12(12):e054958. PubMed ID: 36600427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study.
    Karges B; Tittel SR; Bey A; Freiberg C; Klinkert C; Kordonouri O; Thiele-Schmitz S; Schröder C; Steigleder-Schweiger C; Holl RW
    Lancet Diabetes Endocrinol; 2023 May; 11(5):314-323. PubMed ID: 37004710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prepregnancy care in women with type 1 diabetes improves HbA
    Perea V; Giménez M; Amor AJ; Bellart J; Conget I; Vinagre I
    Diabetes Res Clin Pract; 2019 Aug; 154():75-81. PubMed ID: 31271810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time in range following flash glucose monitoring: Relationship with glycaemic control, diabetes-related distress and resource utilisation in the Association of British Clinical Diabetologists national audit.
    Deshmukh H; Wilmot E; Pieri B; Choudhary P; Shah N; Gregory R; Kilvert A; Lumb A; Christian P; Barnes D; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabet Med; 2022 Nov; 39(11):e14942. PubMed ID: 36054655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon.
    Thieu VT; Mitchell BD; Varnado OJ; Frier BM
    Diabetes Obes Metab; 2020 Apr; 22(4):469-479. PubMed ID: 31820562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
    Ranjan A; Schmidt S; Madsbad S; Holst JJ; Nørgaard K
    Diabetes Obes Metab; 2016 Apr; 18(4):410-8. PubMed ID: 26743775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittently scanned continuous glucose monitoring and hypoglycaemia awareness in drivers with diabetes: Insights from the Association of British Clinical Diabetologists Nationwide audit.
    Mark-Wagstaff C; Deshmukh H; Wilmot EG; Walker N; Barnes D; Parfitt V; Saunders S; Gregory R; Choudhary P; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabetes Obes Metab; 2024 Jan; 26(1):46-53. PubMed ID: 37718554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saxagliptin co-therapy in C-peptide negative Type 1 diabetes does not improve counter-regulatory responses to hypoglycaemia.
    George PS; McCrimmon RJ
    Diabet Med; 2016 Sep; 33(9):1283-90. PubMed ID: 26642301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycaemia and its management in primary care setting.
    Ibrahim M; Baker J; Cahn A; Eckel RH; El Sayed NA; Fischl AH; Gaede P; Leslie RD; Pieralice S; Tuccinardi D; Pozzilli P; Richelsen B; Roitman E; Standl E; Toledano Y; Tuomilehto J; Weber SL; Umpierrez GE
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3332. PubMed ID: 32343474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on the glucagon response to hypoglycaemia during DPP-4 inhibition in elderly subjects with type 2 diabetes: A randomized, placebo-controlled study.
    Farngren J; Persson M; Ahrén B
    Diabetes Obes Metab; 2018 Aug; 20(8):1911-1920. PubMed ID: 29645341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time continuous glucose monitoring as a tool to prevent severe hypoglycaemia in selected pregnant women with Type 1 diabetes - an observational study.
    Secher AL; Stage E; Ringholm L; Barfred C; Damm P; Mathiesen ER
    Diabet Med; 2014 Mar; 31(3):352-6. PubMed ID: 24341466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycaemia during pregnancy in women with Type 1 diabetes.
    Ringholm L; Pedersen-Bjergaard U; Thorsteinsson B; Damm P; Mathiesen ER
    Diabet Med; 2012 May; 29(5):558-66. PubMed ID: 22313112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5).
    Ólafsdóttir AF; Bolinder J; Heise T; Polonsky W; Ekelund M; Wijkman M; Pivodic A; Ahlén E; Schwarcz E; Nyström T; Hellman J; Hirsch IB; Lind M
    Diabetes Obes Metab; 2021 Feb; 23(2):619-630. PubMed ID: 33200487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the day-to-day impact of hypoglycaemia in adults with type 1 or type 2 diabetes: design and validation protocol of the Hypo-METRICS application.
    Søholm U; Broadley M; Zaremba N; Divilly P; Nefs G; Mahmoudi Z; de Galan B; Pedersen-Bjergaard U; Brennan A; Pollard DJ; McCrimmon RJ; A Amiel S; Hendrieckx C; Speight J; Choudhary P; Pouwer F;
    BMJ Open; 2022 Feb; 12(2):e051651. PubMed ID: 35105572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the counter-regulatory responses to hypoglycaemia in patients with type 1 diabetes during opiate receptor blockade with naltrexone.
    Naik S; Belfort-DeAguiar R; Sejling AS; Szepietowska B; Sherwin RS
    Diabetes Obes Metab; 2017 May; 19(5):615-621. PubMed ID: 27987236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent C-peptide is associated with reduced hypoglycaemia but not HbA
    Marren SM; Hammersley S; McDonald TJ; Shields BM; Knight BA; Hill A; Bolt R; Tree TI; Roep BO; Hattersley AT; Jones AG; Oram RA;
    Diabet Med; 2019 Sep; 36(9):1092-1099. PubMed ID: 30955221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
    UK Hypoglycaemia Study Group
    Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term impact of glucose monitoring with the FreeStyle Libre on glycaemic control and hypoglycaemia awareness in people with type 1 diabetes: Insights from the Association of British Clinical Diabetologists national audit.
    Shah N; Deshmukh H; Wilmot EG; Patmore J; Christian P; Barnes DJ; Walton C; Ryder REJ; Sathyapalan T
    Diabet Med; 2023 Jun; 40(6):e15070. PubMed ID: 36797537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.